Braeburn Pharmaceuticals

New York New York United States; New York United States; United States

industry focus

HealthcarePharmaceuticalMedical Devices
Braeburn Pharmaceuticals, an Apple Tree Partners company, develops and commercializes innovative medical products. Upon approval, the company’s first product will be Probuphine®, a buprenorphine implant currently under FDA priority review for the ...
Show more
Relevant investments:
Company
Cost
Round
  • Super company
    Billion
  • Foundersuite
    Million
    Seed A
  • Active Inv
    13 000
    Round Best
Show more